Last updated: February 24, 2023
Sponsor: Azienda Usl di Bologna
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
N/AClinical Study ID
NCT05676086
467-2022-SPER-AUSLBO
Ages > 65 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Living in the three selected cities within the target district chosen for the study
- Women and men
- Age 65 years or older
- Signing informed consent
Exclusion
Exclusion Criteria:
- Lack of or inability to provide informed consent
- Lack of or inability to allow data collection over the course of the study
Study Design
Total Participants: 600
Study Start date:
February 01, 2023
Estimated Completion Date:
December 31, 2023
Study Description
Connect with a study center
Irccs - Istituto Delle Scienze Neurologiche
Bologna, 40139
ItalyActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.